-
Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report.
BMC pulmonary medicine 20160101
-
Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosis.
Annals of the rheumatic diseases 20121201
-
Pathways in pulmonary arterial hypertension: the future is here.
European respiratory review : an official journal of the European Respiratory Society 20121201
-
Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertension.
The American journal of cardiology 20121115
-
Experiences with treprostinil in the treatment of pulmonary arterial hypertension.
Therapeutic advances in respiratory disease 20121001
-
Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY®.
Mayo Clinic proceedings 20120901
-
Baseline NT-proBNP correlates with change in 6-minute walk distance in patients with pulmonary arterial hypertension in the pivotal inhaled treprostinil study TRIUMPH-1.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20120801
-
Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20120701
-
Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist.
Biochemical pharmacology 20120701
-
Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20120601
-
Inhaled treprostinil for the treatment of pulmonary arterial hypertension.
Expert review of respiratory medicine 20120601
-
Cost effectiveness of prostacyclins in pulmonary arterial hypertension.
Applied health economics and health policy 20120501
-
Pulmonary arterial hypertension in the setting of pregnancy: a case series and standard treatment approach.
Lung 20120401
-
Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: the impact of late referral.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20120401
-
Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation.
American journal of respiratory cell and molecular biology 20120301
-
[Progress in pharmacotherapy of pulmonary arterial hypertension in children].
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20120301
-
Prostacyclin receptor-mediated ATP release from erythrocytes requires the voltage-dependent anion channel.
American journal of physiology. Heart and circulatory physiology 20120201
-
The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension.
Chest 20120101
-
Effect of prostaglandin I2 analogs on cytokine expression in human myeloid dendritic cells via epigenetic regulation.
Molecular medicine (Cambridge, Mass.) 20120101
-
Inhaled treprostinil: a therapeutic review.
Drug design, development and therapy 20120101
-
Smooth muscle myosin inhibition: a novel therapeutic approach for pulmonary hypertension.
PloS one 20120101
-
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20111201
-
Inhaled treprostinil for the treatment of pulmonary arterial hypertension.
Critical care nurse 20111201
-
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
PLoS computational biology 20111201
-
Treprostinil, a prostacyclin analog, ameliorates ischemia-reperfusion injury in rat orthotopic liver transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20111101
-
Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.
Expert opinion on pharmacotherapy 20111101
-
Treprostinil inhibits the adhesion and differentiation of fibrocytes via the cyclic adenosine monophosphate-dependent and Ras-proximate protein-dependent inactivation of extracellular regulated kinase.
American journal of respiratory cell and molecular biology 20111001
-
Prostaglandin I2 analogs suppress tumor necrosis factor α production and the maturation of human monocyte-derived dendritic cells.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 20111001
-
Cutaneous reaction to inhaled treprostinil.
Journal of the American Academy of Dermatology 20111001
-
Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20110901
-
Differential response to intravenous prostacyclin analog therapy in patients with pulmonary arterial hypertension.
Pulmonary pharmacology & therapeutics 20110801
-
Prostaglandin I(2) analogues suppress TNF-α expression in human monocytes via mitogen-activated protein kinase pathway.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20110701
-
[Treatment of idiopathic pulmonary arterial hypertension].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20110701
-
The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.
Therapeutic advances in respiratory disease 20110601
-
Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension.
The Journal of pediatrics 20110401
-
Constrictive-like physiology in severe pulmonary hypertension: the effect of the Valsalva maneuver.
Southern medical journal 20110401
-
Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension.
Angiogenesis 20110301
-
Cathodal iontophoresis of treprostinil and iloprost induces a sustained increase in cutaneous flux in rats.
British journal of pharmacology 20110201
-
Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: literature review and case presentation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20110201
-
Effects of PGI2 analogues on Th1- and Th2-related chemokines in monocytes via epigenetic regulation.
Journal of molecular medicine (Berlin, Germany) 20110101
-
Overview of current therapeutic approaches for pulmonary hypertension.
Pulmonary circulation 20110101
-
[The man from the kingdom of the near-dead - modern treatment of pulmonary hypertension].
Kardiologia polska 20110101
-
Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report.
International journal of general medicine 20110101
-
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension.
The European respiratory journal 20101201
-
Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension.
American journal of respiratory and critical care medicine 20101101
-
Subcutaneous treprostinil in pulmonary arterial hypertension: Practical considerations.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20101101
-
The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part II: Medical Treatment - Study Results.
Current cardiology reviews 20101101
-
Prostaglandin I(2) analogues enhance growth-related oncogene-alpha expression in human monocyte-derived dendritic cells.
Inflammation 20101001
-
Selexipag: a selective prostacyclin receptor agonist that does not affect rat gastric function.
The Journal of pharmacology and experimental therapeutics 20101001
-
Prostacyclin administration errors in pulmonary arterial hypertension patients admitted to hospitals in the United States: a national survey.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20100801
-
Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
Circulation research 20100723
-
Lack of a pharmacokinetic interaction between oral treprostinil and bosentan in healthy adult volunteers.
Journal of clinical pharmacology 20100701
-
Stability and antimicrobial effectiveness of treprostinil sodium in Sterile Diluent for Flolan.
International journal of clinical practice 20100601
-
Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
Journal of the American College of Cardiology 20100504
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20100501
-
Targeting of the prostacyclin specific IP1 receptor in lungs with molecular conjugates comprising prostaglandin I2 analogues.
Biomaterials 20100401
-
Prostacyclin in the intensive care setting.
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 20100301
-
Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20100201
-
The globalization of clinical trials in pulmonary arterial hypertension.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20100201
-
Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis.
Respiratory research 20100101
-
Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?
BMC cardiovascular disorders 20100101
-
The PPARbeta/delta agonist GW0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension.
PloS one 20100101
-
Inhaled treprostinil and pulmonary arterial hypertension.
Vascular health and risk management 20100101
-
Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension.
Infection control and hospital epidemiology 20090901
-
Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantation.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20090901
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20090901
-
Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease.
Transplant international : official journal of the European Society for Organ Transplantation 20090501
-
Primary pulmonary hypertension as a manifestation of adult multi-system mitochondrial disorder.
Yonsei medical journal 20090430
-
Addition of prostanoids in pulmonary hypertension deteriorating on oral therapy.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20090301
-
A pediatric case study of treprostinil overdose.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20090301
-
Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension.
Pulmonary pharmacology & therapeutics 20090201
-
Portopulmonary hypertension.
Current gastroenterology reports 20090201
-
Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
Pulmonary pharmacology & therapeutics 20081001
-
Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan.
Chest 20080701
-
Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes.
Microcirculation (New York, N.Y. : 1994) 20080701
-
Treprostinil for the treatment of pulmonary hypertension.
Expert opinion on pharmacotherapy 20080601
-
Treprostinil for pulmonary hypertension.
Vascular health and risk management 20080601
-
Long-term experience after transition from parenteral prostanoids to oral agents in patients with pulmonary hypertension.
Respiratory medicine 20080501
-
Treatment of a nonhealing saphenous vein harvest graft with treprostinil sodium.
The Annals of thoracic surgery 20080401
-
Bloodstream infections in patients given treatment with intravenous prostanoids.
Infection control and hospital epidemiology 20080401
-
Patient safety challenges in treprostinil therapy.
Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses 20080401
-
Advances in diagnosis and treatment in patients with pulmonary arterial hypertension.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20080201
-
[Treprostinil therapy for distal chronic thromboembolic pulmonary hypertension].
Kardiologia polska 20080201
-
Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion.
Journal of clinical pharmacology 20080101
-
A novel catheter system for totally implantable intravenous drug therapy: assessment of catheter function and patency with trepostinil therapy.
The journal of vascular access 20080101
-
The role of treprostinil in the management of pulmonary hypertension.
American journal of cardiovascular drugs : drugs, devices, and other interventions 20080101
-
A clinical comparison of slow- and rapid-escalation treprostinil dosing regimens in patients with pulmonary hypertension.
Clinical pharmacokinetics 20080101
-
Advances in prostanoid infusion therapy for pulmonary arterial hypertension.
Journal of infusion nursing : the official publication of the Infusion Nurses Society 20080101
-
Nebulized milrinone use in a pulmonary hypertensive crisis.
Pharmacotherapy 20071201
-
Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20071101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20071101
-
IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues.
Biochemical and biophysical research communications 20070907
-
Transition from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial.
Chest 20070901
-
Transition from IV to subcutaneous prostacyclin: premature withdrawal?
Chest 20070901
-
Treprostinil potentiates the positive inotropic effect of catecholamines in adult rat ventricular cardiomyocytes.
British journal of pharmacology 20070701
-
Practical aspects of continuous intravenous treprostinil therapy.
Critical care nurse 20070401
-
Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia.
Chest 20070401
-
[Long-term experience with trerpostinil infusion treatment in patients with pulmonary arterial hypertension in the Czech Republic].
Vnitrni lekarstvi 20070401
-
Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension--seven sites, United States, 2003-2006.
MMWR. Morbidity and mortality weekly report 20070302
-
Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil.
The American journal of cardiology 20070301
-
Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension.
Journal of thrombosis and haemostasis : JTH 20070301
-
Prostanoid therapy for pulmonary arterial hypertension.
Clinics in chest medicine 20070301
-
[Pulmonary hypertension treatment: future prospects].
Archivos de bronconeumologia 20070301
-
Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities.
Journal of immunology (Baltimore, Md. : 1950) 20070201
-
Assessment and treatment of pulmonary arterial hypertension: an Australian perspective in 2006.
Internal medicine journal 20070101
-
Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension.
Journal of cardiovascular pharmacology 20070101
-
The role of peroxisome proliferator-activated receptors in pulmonary vascular disease.
PPAR research 20070101
-
The Role of PPARs in Lung Fibrosis.
PPAR research 20070101
-
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil.
The European respiratory journal 20061201
-
Long-term treprostinil in pulmonary arterial hypertension: Is the glass half full or half empty?
The European respiratory journal 20061201
-
[Pulmonary arterial hypertension and systemic sclerosis].
Presse medicale (Paris, France : 1983) 20061201
-
Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study.
Chest 20061101
-
Treprostinil in advanced experimental pulmonary hypertension: beneficial outcome without reversed pulmonary vascular remodeling.
Journal of cardiovascular pharmacology 20061101
-
Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies.
Journal of the American College of Cardiology 20061017
-
Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension.
Journal of the American College of Cardiology 20061003
-
Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan.
European journal of clinical investigation 20060901
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20060901
-
Treprostinil for the treatment of pulmonary arterial hypertension in patients with New York Heart Association class II-IV symptoms.
Pharmacotherapy 20060801
-
Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.
Heart (British Cardiac Society) 20060701
-
An evidence-based approach to the management of pulmonary arterial hypertension.
Current opinion in cardiology 20060701
-
[Update in the diagnosis and therapy for pulmonary arterial hypertension].
Revista medica de Chile 20060701
-
Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension.
Chest 20060601
-
A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis.
Journal of the American Academy of Dermatology 20060501
-
Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial.
Chest 20060301
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20060301
-
Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts.
American journal of respiratory cell and molecular biology 20060201
-
Digital ulcers in patients with systemic sclerosis.
Autoimmunity reviews 20060201
-
Inhaled treprostinil [corrected] for treatment of chronic pulmonary arterial hypertension.
Annals of internal medicine 20060117
-
The prostacyclin analog, treprostinil sodium, provides symptom relief in severe Buerger's disease--a case report and review of literature.
Angiology 20060101
-
[The best of clinical cardiovascular pharmacology in 2005].
Archives des maladies du coeur et des vaisseaux 20060101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20060101
-
[Clinical implications and prognostic significance of the study on the circadian variation of heart rate variability in patients with severe pulmonary hypertension].
Gaceta medica de Mexico 20060101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20060101
-
Treprostinil sodium (Remodulin), a prostacyclin analog, in the treatment of critical limb ischemia: open-label study.
Vascular 20060101
-
Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension.
The journal of vascular access 20060101
-
Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.
American journal of respiratory and critical care medicine 20051215
-
Potent effects of aerosol compared with intravenous treprostinil on the pulmonary circulation.
Journal of applied physiology (Bethesda, Md. : 1985) 20051201
-
New therapeutic agents for pulmonary vascular disease.
Paediatric respiratory reviews 20051201
-
Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension.
Current medical research and opinion 20051201
-
Effects of aerosol vs IV UT-15 on prostaglandin H2 analog-induced pulmonary hypertension in sheep.
Chest 20051201
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20051201
-
Combining treprostinil and sildenafil in the treatment of pulmonary hypertension.
Internal medicine journal 20051101
-
Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.
The American journal of cardiology 20051101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20050901
-
Prostacyclin therapy for pulmonary arterial hypertension: new directions.
Seminars in respiratory and critical care medicine 20050801
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20050601
-
Prostacyclin for pulmonary hypertension in adults.
The Cochrane database of systematic reviews 20050418
-
Staggered transition to epoprostenol from treprostinil in pulmonary arterial hypertension.
The Annals of pharmacotherapy 20050401
-
Treprostinil for the treatment of severe digital necrosis in systemic sclerosis.
Vascular medicine (London, England) 20050201
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20050101
-
Cost-effectiveness of treprostinil versus epoprostenol in patients with pulmonary arterial hypertension: a Canadian analysis.
Canadian respiratory journal 20050101
-
Transition from epoprostenol and treprostinil to the oral endothelin receptor antagonist bosentan in patients with pulmonary hypertension.
Chest 20040901
-
Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers.
Journal of cardiovascular pharmacology 20040801
-
Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.
Chest 20040801
-
Prostanoid therapy for pulmonary arterial hypertension.
Journal of the American College of Cardiology 20040616
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20040601
-
Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion.
Journal of clinical pharmacology 20040501
-
Advances in prostacyclin therapy for pulmonary arterial hypertension.
Critical care nurse 20040401
-
The intramolecular asymmetric Pauson-Khand cyclization as a novel and general stereoselective route to benzindene prostacyclins: synthesis of UT-15 (treprostinil).
The Journal of organic chemistry 20040319
-
Current medical treatment of pulmonary arterial hypertension.
The Mount Sinai journal of medicine, New York 20040301
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20040301
-
Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension.
Drugs of today (Barcelona, Spain : 1998) 20040301
-
Treprostinil for pulmonary hypertension.
Expert review of cardiovascular therapy 20040301
-
Absolute bioavailability and pharmacokinetics of treprostinil sodium administered by acute subcutaneous infusion.
Journal of clinical pharmacology 20040101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20040101
-
Drug therapy for pulmonary arterial hypertension: what's on the menu today?
Chest 20031201
-
Treatment of pulmonary arterial hypertension: a preliminary decision analysis.
Chest 20031201
-
[Sildenafil as a substitute for subcutaneous prostacyclin in pulmonary hypertension].
Archivos de bronconeumologia 20031001
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20030901
-
[Transition from intravenous to subcutaneous prostacyclin in pulmonary hypertension].
Revista espanola de cardiologia 20030801
-
New drugs 2003, part II.
Nursing 20030701
-
Effect of continuous subcutaneous treprostinil therapy on the pharmacodynamics and pharmacokinetics of warfarin.
Journal of cardiovascular pharmacology 20030601
-
Clinical value of prostacyclin and its analogs in the management of pulmonary arterial hypertension.
Current vascular pharmacology 20030601
-
Stability and preservative effectiveness of treprostinil sodium after dilution in common intravenous diluents.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030501
-
[Treatment of HIV-associated pulmonary hypertension with treprostinil].
Revista espanola de cardiologia 20030401
-
Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension.
Cleveland Clinic journal of medicine 20030401
-
Advances in the treatment of secondary pulmonary hypertension.
Current opinion in pulmonary medicine 20030301
-
Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension.
Journal of cardiovascular pharmacology 20030201
-
Understanding primary pulmonary hypertension.
Critical care nursing quarterly 20030101
-
[Role of prostacyclin and its derivatives in the treatment of pulmonary arterial hypertension].
Medicina 20030101
-
[What is new in the treatment of pulmonary artery hypertension?].
Archivos de cardiologia de Mexico 20030101
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20021201
-
Treprostinil therapy for pulmonary artery hypertension.
Expert opinion on investigational drugs 20021101
-
The new clinical trials on pharmacological treatment in pulmonary arterial hypertension.
The European respiratory journal 20021001
-
Treprostinil (Remodulin) for pulmonary arterial hypertension.
The Medical letter on drugs and therapeutics 20020916
-
The prostacyclin analogue treprostinil blocks NFkappaB nuclear translocation in human alveolar macrophages.
The Journal of biological chemistry 20020906
-
From the Food and Drug Administration.
JAMA 20020703
-
Treprostinil sodium Pharmacia.
Current opinion in investigational drugs (London, England : 2000) 20020401
-
Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery.
American journal of respiratory cell and molecular biology 20020201
-
Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response.
American journal of physiology. Regulatory, integrative and comparative physiology 20020101
-
Emerging medical therapies for pulmonary arterial hypertension.
Progress in cardiovascular diseases 20020101
-
Report from the 93rd Cardiovascular and Renal Drugs Advisory Committee Meeting, August 9-10, 2001.
Circulation 20011009
-
Medical therapy of pulmonary hypertension. The prostacyclins.
Clinics in chest medicine 20010901
-
New and experimental therapies for pulmonary hypertension.
Clinics in chest medicine 20010901
